Family Dollar Stores, Inc. (FDO) Blamed Me For Dollar General Corp. (DG) Being Not Interested: Carl Icahn

After Dollar General Corp. (NYSE:DG) made a bid for Family Dollar Stores, Inc. (NYSE:FDO) earlier this week, Family Dollar Stores, Inc. (NYSE:FDO)’s Board is at a crossroad. Few weeks back Dollar Tree, Inc. (NASDAQ:DLTR) had announced its decision of acquiring Family Dollar Stores, Inc. (NYSE:FDO), and everyone, including billionaire investor Carl Icahn was surprised that Dollar Tree, Inc. (NASDAQ:DLTR) made the bid instead of Dollar General Corp. (NYSE:DG). Now, Family Dollar Stores, Inc. (NYSE:FDO)  blames Icahn for Dollar General Corp. (NYSE:DG) not being interested in it earlier. Icahn clarified these allegations on CNBC in an interview on Tuesday.

“[…] I am certainly happy for the IEP shareholders that benefit from this, the only thing that irks me about it is, again and I keep repeating this at the risk of being corny, I really do care about corporate governance. So, I think this is an example of why the system is so dysfunctional […],” Icahn said.

Hedge Fund Strategies

Icahn revealed that recently he had a ‘friendly’ dinner at his apartment along with Family Dollar Stores, Inc. (NYSE:FDO)’s CEO, Howard Levine, some of the company’s board members and Icahn’s own staff. The billionaire investor mentioned that though he didn’t bring up the topic, people from Family Dollar Stores, Inc. (NYSE:FDO) started discussing about the takeover and blamed him for Dollar General Corp. (NYSE:DG) being disinterested earlier in acquiring Family Dollar Stores, Inc. (NYSE:FDO). Icahn said that he found this ‘completely disingenuous’.

“[…] His [Howard Levine] ego was involved, I am an old poker player and this is the way I saw it. He mentioned it several times that the CEO who ran it for all these years is to be blamed and I said to him, “Well, what happened in the 10 years that you were running it?” […]” Icahn added.

Disclosure: None

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!